Form 4 Filing for Michael O'Kronley

This Form 4 filing details the equity holdings of Michael O'Kronley, Chief Executive Officer of NOVONIX Ltd. The filing includes information on performance rights, which are set to vest based on a 3-year Total Shareholder Return (TSR) performance, subject to a revenue modifier. These rights are exercisable on December 31, 2027, and expire on December 31, 2028. The performance rights are associated with 3,723,971 underlying ordinary shares of NOVONIX Ltd. The exercise price is reported as 0. The reporting owner, Michael O'Kronley, has a direct ownership interest in these securities.